Shanghai Pudong New Area Mental Health Center, The Affiliated Brain Hospital of Guangzhou Medical University: Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy. ClinicalTrials.gov, 1.9.2022, nro NCT03652974. ClinicalTrials.gov. Artikkelin verkkoversio.
Richard D. Hayes, Johnny Downs, Chin-Kuo Chang, Richard G. Jackson, Hitesh Shetty, Matthew Broadbent: The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders. Schizophrenia Bulletin, 2015-5, nro 3, s. 644–655. PubMed:25154620doi:10.1093/schbul/sbu120ISSN 0586-7614Artikkelin verkkoversio.
Mark Ponsford, Daniel Castle, Tayyeb Tahir, Rebecca Robinson, Wendy Wade, Rachael Steven: Clozapine is associated with secondary antibody deficiency. The British Journal of Psychiatry: The Journal of Mental Science, 27.9.2018, s. 1–7. PubMed:30259827doi:10.1192/bjp.2018.152ISSN 1472-1465Artikkelin verkkoversio.
Hamza Ayaydın, Şermin Bilgen Ulgar: Control of seizures in a clozapine-treated schizophrenia patient, using valproate: a case report. Psychiatry and Clinical Psychopharmacology, 2.10.2019, 29. vsk, nro 4, s. 529–532. doi:10.1080/24750573.2018.1468640ISSN 2475-0573Artikkelin verkkoversio. (englanniksi)
Richard D. Hayes, Johnny Downs, Chin-Kuo Chang, Richard G. Jackson, Hitesh Shetty, Matthew Broadbent: The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders. Schizophrenia Bulletin, 2015-5, nro 3, s. 644–655. PubMed:25154620doi:10.1093/schbul/sbu120ISSN 0586-7614Artikkelin verkkoversio.
Mark Ponsford, Daniel Castle, Tayyeb Tahir, Rebecca Robinson, Wendy Wade, Rachael Steven: Clozapine is associated with secondary antibody deficiency. The British Journal of Psychiatry: The Journal of Mental Science, 27.9.2018, s. 1–7. PubMed:30259827doi:10.1192/bjp.2018.152ISSN 1472-1465Artikkelin verkkoversio.
ncbi.nlm.nih.gov
Richard D. Hayes, Johnny Downs, Chin-Kuo Chang, Richard G. Jackson, Hitesh Shetty, Matthew Broadbent: The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders. Schizophrenia Bulletin, 2015-5, nro 3, s. 644–655. PubMed:25154620doi:10.1093/schbul/sbu120ISSN 0586-7614Artikkelin verkkoversio.
Hamza Ayaydın, Şermin Bilgen Ulgar: Control of seizures in a clozapine-treated schizophrenia patient, using valproate: a case report. Psychiatry and Clinical Psychopharmacology, 2.10.2019, 29. vsk, nro 4, s. 529–532. doi:10.1080/24750573.2018.1468640ISSN 2475-0573Artikkelin verkkoversio. (englanniksi)
Richard D. Hayes, Johnny Downs, Chin-Kuo Chang, Richard G. Jackson, Hitesh Shetty, Matthew Broadbent: The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders. Schizophrenia Bulletin, 2015-5, nro 3, s. 644–655. PubMed:25154620doi:10.1093/schbul/sbu120ISSN 0586-7614Artikkelin verkkoversio.
Mark Ponsford, Daniel Castle, Tayyeb Tahir, Rebecca Robinson, Wendy Wade, Rachael Steven: Clozapine is associated with secondary antibody deficiency. The British Journal of Psychiatry: The Journal of Mental Science, 27.9.2018, s. 1–7. PubMed:30259827doi:10.1192/bjp.2018.152ISSN 1472-1465Artikkelin verkkoversio.
Hamza Ayaydın, Şermin Bilgen Ulgar: Control of seizures in a clozapine-treated schizophrenia patient, using valproate: a case report. Psychiatry and Clinical Psychopharmacology, 2.10.2019, 29. vsk, nro 4, s. 529–532. doi:10.1080/24750573.2018.1468640ISSN 2475-0573Artikkelin verkkoversio. (englanniksi)